159 related articles for article (PubMed ID: 37248973)
1. [Drug-induced bile duct injury: progress and challenges].
Li DL
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced bile duct injury.
Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced Bile Duct Injury - A Short Review.
Dobreva I; Karagyozov P
Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
5. Xenobiotic-induced liver injury and fibrosis.
Österreicher CH; Trauner M
Expert Opin Drug Metab Toxicol; 2012 May; 8(5):571-80. PubMed ID: 22452290
[TBL] [Abstract][Full Text] [Related]
6. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
Xie W; Wang Q; Gao Y; Pan CQ
BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
Nakanishi Y; Saxena R
Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced bile duct injury: new agents, new mechanisms.
Scoazec JY
Curr Opin Gastroenterol; 2022 Mar; 38(2):83-88. PubMed ID: 34931623
[TBL] [Abstract][Full Text] [Related]
9. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
Conrad MA; Cui J; Lin HC
J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
[TBL] [Abstract][Full Text] [Related]
10. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
11. [Secondary drug-induced cholestasis with bile duct involvement].
Horsmans Y; Harvengt C
Acta Gastroenterol Belg; 1991; 54(1):27-33. PubMed ID: 2058347
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine-induced vanishing bile duct syndrome in a child.
Bhayana H; Appasani S; Thapa BR; Das A; Singh K
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
[No Abstract] [Full Text] [Related]
13. Vanishing bile duct syndrome in drug-induced liver disease.
Desmet VJ
J Hepatol; 1997; 26 Suppl 1():31-5. PubMed ID: 9138126
[No Abstract] [Full Text] [Related]
14. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
[TBL] [Abstract][Full Text] [Related]
15. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review.
Levine C; Trivedi A; Thung SN; Perumalswami PV
Semin Liver Dis; 2014 May; 34(2):246-51. PubMed ID: 24879988
[TBL] [Abstract][Full Text] [Related]
16. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine hepatotoxicity: another cause of the vanishing bile duct syndrome.
Forbes GM; Jeffrey GP; Shilkin KB; Reed WD
Gastroenterology; 1992 Apr; 102(4 Pt 1):1385-8. PubMed ID: 1551543
[TBL] [Abstract][Full Text] [Related]
19. Hydroxycut-related Vanishing Bile Duct Syndrome.
Adike A; Smith ML; Chervenak A; Vargas HE
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):142-144. PubMed ID: 27151488
[No Abstract] [Full Text] [Related]
20. Secondary sclerosing cholangitis in patients with drug-induced liver injury.
Gudnason HO; Björnsson HK; Gardarsdottir M; Thorisson HM; Olafsson S; Bergmann OM; Björnsson ES
Dig Liver Dis; 2015 Jun; 47(6):502-7. PubMed ID: 25840876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
